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The Adult Spinal Cord Harbors a Population
of GFAP-Positive Progenitors with Limited
Self-Renewal Potential
Roberto Fiorelli,1 Arantxa Cebrian-Silla,2 Jose-Manuel Garcia-Verdugo,2
and Olivier Raineteau1
Adult neural stem cells (aNSCs) of the forebrain are GFAP-expressing cells that are intercalated within ependymal cells of the
subventricular zone (SVZ). Cells showing NSCs characteristics in vitro can also be isolated from the periaqueductal region in
the adult spinal cord (SC), but contradicting results exist concerning their glial versus ependymal identity. We used an induci-
ble transgenic mouse line (hGFAP-CreERT2) to conditionally label GFAP-expressing cells in the adult SVZ and SC periaque-
duct, and directly and systematically compared their self-renewal and multipotential properties in vitro. We demonstrate that
a population of GFAP1 cells that share the morphology and the antigenic properties of SVZ-NSCs mostly reside in the dorsal
aspect of the central canal (CC) throughout the spinal cord. These cells are non-proliferative in the intact spinal cord, but
incorporate the S-phase marker EdU following spinal cord injury. Multipotent, clonal YFP-expressing neurospheres (i.e., deriv-
ing from recombined GFAP-expressing cells) were successfully obtained from both the intact and injured spinal cord. These
spheres however showed limited self-renewal properties when compared with SVZ-neurospheres, even after spinal cord injury.
Altogether, these results demonstrate that significant differences exist in NSCs lineages between neurogenic and non-
neurogenic regions of the adult CNS. Thus, although we confirm that a population of multipotent GFAP1 cells co-exists
alongside with multipotent ependymal cells within the adult SC, we identify these cells as multipotent progenitors showing
limited self-renewal properties.
GLIA 2013;61:2100–2113
Key Words: SVZ, neural stem cells, astrocytes, ependymal cells, spinal cord injury
Introduction
During the development of the vertebrate central nervoussystem (CNS), peri-ventricular radial glial (RG) cells
self-renew through asymmetric division and sequentially give
rise to neurons, ependymal cells, and glial cells throughout
the brain (Anthony et al., 2004; Kriegstein and Alvarez-
Buylla, 2009). Lineage tracing studies at perinatal stages have
revealed that RG transform into aNSCs that persist within
the subventricular zone (SVZ) of the lateral ventricle and pro-
duce new neurons and glia throughout adulthood (Doetsch
et al., 1999; Ganat et al., 2006; Lledo et al., 2008; Merkle
et al., 2004). These adult neurogenic NSCs retain a number
of radial glia properties, such as an expression of Glial Fibril-
lary Acidic Protein (GFAP), Nestin, Vimentin, and BLBP
(Doetsch et al., 1999) and the presence of an apical process
contacting the lumen of the ventricle opposing a longer basal
process (Mirzadeh et al., 2008). They can be isolated and cul-
tured in vitro in the presence of mitotic factors, forming mul-
tipotent, self-renewing neurospheres (Golmohammadi et al.,
2008; Weiss et al., 1996), while juxtaposed GFAP-negative
ependymal cells fail to do so (Pfenninger et al., 2011).
Neurosphere-forming cells can also be isolated from
non-neurogenic regions of the CNS, such as the spinal cord
(Martens et al., 2002; Shihabuddin et al., 2000; Weiss et al.,
1996). Notably, SC-derived neurospheres show in vitro multi-
potency and self-renewal properties identical to cultures
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prepared from the SVZ (Weiss et al., 1996). Furthermore,
spinal cord injuries (SCI) greatly increase the yield of
neurospheres-forming cells (Ohori et al., 2006; Yamamoto
et al., 2001). These observations together with their obvious
therapeutic potential (Hofstetter et al., 2005; Ohori et al.,
2006; Yang et al., 2006), raised the interest to identify
neurospheres-forming cells in the adult spinal cord. Microdis-
section of the SC central canal (CC) as well as fate mapping
studies support a peri-acqueductal origin of NSCs, while they
exclude a contribution of parenchymal glial cells to neuro-
spheres formation (Barnabe-Heider et al., 2010; Martens
et al., 2002; Sabourin et al., 2009). Unresolved issues how-
ever persist regarding the ependymal versus glial nature of
neurosphere-forming cells in the spinal cord CC. While fate
mapping studies concluded for an ependymal identity of SC
sphere forming cells (Meletis et al., 2008), recent work high-
lighted the presence of GFAP-expressing cells intermingled
with ependymal cells (Ecc) by fluorescent (Hamilton et al.,
2009) as well by electron microscopy (Alfaro-Cervello et al.,
2012). These GFAP-expressing cells present a basal process
that contact the lumen of the central canal, and have there-
fore been defined as central canal-contacting astrocytes (i.e.,
Acc; Alfaro-Cervello et al., 2012).
Exploring similarities in the glial identity of
neurosphere-forming cells in the adult SC and SVZ has so
far been hampered by the use of distinct promoters to label
and study these cells by transgenesis. Here, we used an induc-
ible transgenic mouse model expressing CreERT2 under the
human GFAP (hGFAP) promoter (Ganat et al., 2006) to
directly and systematically compare the self-renewal and mul-
tipotent potential of GFAP-expressing cells isolated from
these two regions. Using this transgenic approach, we show
efficient recombination in a population of adult SVZ-NSCs
as well as in a population of mainly non-proliferative Acc
around the spinal cord CC. While these two cell populations
display many morphological and antigenic similarities, our
results highlight differences in their capacity to generate self-
renewing neurospheres in vitro, even after spinal cord injury.
Our work confirms the existence of GFAP-expressing
cells (i.e., Acc cells) co-existing with ependymal cells in the
spinal cord CC. These Acc participate to the generation of
multipotent neurospheres, but show restricted self-renewal
properties compared with Ecc-derived neurospheres or GFAP-
expressing SVZ-NSCs, even after injury. These results high-
light the heterogeneity of cell lineages showing NSCs proper-
ties along the adult CNS axis.
Materials and Methods
Ethics Statement
All experimental protocols were approved by the Veterinary Depart-
ment of the Canton of Zurich (License 182/2011). Animal proce-
dures were executed in accordance with Swiss law, with strict
consideration given to the care and use of animals.
Animals
Transgenic mice expressing the conditional cre recombinase (i.e.,
CreERT2) under control of the human GFAP promoter (i.e.,
hGFAP; Hirrlinger et al., 2006) were crossed with the reporter
mouse line ROSA26-Flox-Stop-Flox YFP (Jackson Laboratories)
under standard conditions. A total of 64 mice (males and females)
of 2–5 months of age were used in this study. Recombination was
induced by two daily intraperitoneal (i.p.) injections of 25 mM
Tamoxifen (Sigma, CH) dissolved in Corn Oil (Sigma, CH) 10%
EtOH, for 5 consecutive days.
Spinal Cord Injury, EdU Labeling, and Tissue
Processing
SC injuries were performed under deep anesthesia (Hypnorm:
fentanyl-citrate 0.7 mg/kg, fluanison 22.5 mg/kg, Janssen Pharma-
ceutics; Dormicum: midazolamum 22.5 mg/kg, Roche Pharmaceu-
tics, CH). A dorsal laminectomy was performed at T8 spinal level,
and a dorsal compression injury was administered by delivering a
constant force of 2 cN for 2 s onto the exposed spinal cord. Imme-
diately following injury, muscles were sewed and the skin stitched.
Animals were allowed to recover for 4 days during which analgesic
(Rimadyl, Pfizer, 5 mg/kg) and antibiotics (Baytril, Bayer, DE 5 mg/
kg) were administered. Bladder was manually emptied twice daily.
To label mitotic cells, two daily doses of 50 mg/kg EdU (Invi-
trogen) were administered i.p. to 2-month-old animals, in the 3 days
following the injury. Non-injured animals were subjected to a similar
protocol of EdU administration. Mice were sacrificed 2 h following
the last EdU injection, i.e., at 4 days post-injury (d.p.i.), by terminal
euthanasia with pentobarbital. Tissues were fixed through intracardial
perfusion with Ringer’s solution (Fresenius Kabi, DE) supplemented
with 40 mM NaNO2, 2 mM NaCHO3, and 50 IE/mL Heparin,
followed by 4% paraformaldehyde in 0.1M phosphate buffer (PB).
Tissues were cryoprotected by immersion in PB 30% sucrose for 2
days before being cut into 40 mm coronal or sagittal sections using a
cryostat (Microm HM560, www.microm.de).
Immunostaining Procedure
Immunohistochemistry was performed on free-floating sections. For
immunodetection of nuclear antigens, tissues were treated for 45 min
in citrate buffer (pH 6) at 80C. Following permeabilization and
blocking in 0.1M PB supplemented with 0.4% Triton-X (i.e., PBTx)
and 10% heat-inactivated horse serum (HS), the sections were incu-
bated with the primary antibodies for 12–36 h at 4C in PBTx, 2%
HS. Incubation with secondary antibodies was performed for 2–4 h at
4C in PBTx, 2% HS. When biotin-conjugated secondary antibodies
were used, sections were subsequently incubated with fluorescent
Alexa-conjugated streptavidin (Jackson ImmunoResearch, USA), 1:500
in 0.1M PBTx for 100 at room temperature. Nuclear counterstaining
was achieved with DAPI (0.5 mg/mL) or TOPRO-3 (0.05 mM, Invi-
trogen). Fluorescent detection of EdU-labeled cells was performed
using the Click-it EdU Alexa Fluor 555 kit (Invitrogen) following
manufacturer’s guidelines. Primary antibodies used in the study were:
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rabbit anti-GFAP (1:500, DAKO, DE), mouse anti-GFAP (1:500,
Millipore), mouse anti-NeuN (1:500, Millipore), mouse anti-CC1
(1:400, Calbiochem), mouse anti-Map2 (1:500, Sigma-Aldrich, CH),
chicken anti-GFP (1:1000, Abcam, UK), mouse anti-RIP (1:200,
Developmental Studies Hybridoma Bank), mouse anti-Mash1 (1:100,
BD Pharmaceutics), rabbit anti-ID1 (1:500, Biocheck), goat anti-DCX
(1:500, Santa Cruz) mouse anti-Nestin (1:400, BD Pharmaceutics),
chicken anti-Vimentin (1:1000, Millipore), rabbit anti-Olig2 (1:500,
Millipore), rabbit anti-BLBP (1:300, Abcam, UK), mouse anti-
bcatenin (1:500, BD Pharmaceutics), rabbit anti-Sox2 (1:200, Abcam,
UK), and rabbit anti-Connexin-30 (Cx-30, 1:500, Invitrogen). Species-
matching secondary Alexa-conjugated (Invitrogen) or biotin-conjugated
(Jackson Immunoresearch) antibodies raised in donkey were used at
1:1000 dilution. Immunostainings on cultured cells were performed as
described above, whereas incubation times and dilutions of primary
and secondary antibodies were halved. Following the staining proce-
dure, sections were mounted on gelatin-coated slides. Both histological
samples and cultures were coverslipped with anti-fading mounting
medium Vectashield (Vector Lab).
Neurospheres Cultures
Progenitor cells were isolated from the SVZ of adult GFAPCreRT2
mice 7 days following induction of recombination. The SVZ was care-
fully microdissected from the rostral ventricular opening to the
appearance of the fimbria. Alternatively, the whole SC was extracted
(11 days post-recombination, i.e., 4 days following injury), and the
meninges carefully removed to avoid contamination from other
neurospheres-generating cell populations (Decimo et al., 2011). Tis-
sues were digested with a solution of DNAse I (Worthington), Papain
(Worthington), and Dispase II (Roche, CH), subsequently triturated
with fire-polished glass Pasteur pipettes of decreasing diameters. Single
cells suspensions were filtered through a 70 mm cell strainer (BD Fal-
con); for SC cultures, myelin debris was removed via continuous gra-
dient centrifugation in 0.5 3 HBSS/30% sucrose. About 20 3 103
viable cells (i.e., 10 cells/mL) were plated into 2 mL of DMEM/F12
medium supplemented with N2 (Gibco), EGF, FGF2 (both 20 ng/
mL, Peprotech), heparin (1 mg/mL), and antibiotic/antimycotic, in 2
cm Petri dishes. Primary spheres appeared in culture after 7–14 days
in vitro (d.i.v.), and were then passaged after mechanical trituration.
Subsequent passages were performed after 4–7 d.i.v., when the diame-
ter of the majority of the neurospheres reached 50 mm. For differen-
tiation studies, neurospheres were selected manually and plated onto
Polylysine/laminin treated dishes and cultured in Neurobasal A sup-
plemented with B27 (Gibco), Glutamax 0.5 mM, and antibiotics/anti-
mycotic. All culture media were refreshed every second day. Cells were
fixed with 4% paraformaldehyde after 3 or 14 d.i.v.
Microscopy and Analysis
IMMUNOGOLD STAINING AND TRANSMISSION ELEC-
TRON MICROSCOPY. Mice (n 5 2) were perfused with 0.9%
saline, followed by 4% paraformaldehyde (PFA) and 0.5% glutaral-
dehyde (EMS, Hatfield, PA). Spinal cords were post-fixed overnight
in 4% PFA then microdissected and 50 lm spinal cord sections
were cut on a vibratome (Leica). Pre-embedding immunogold stain-
ing was performed by incubating sections in chicken anti-GFP pri-
mary antibody (1:200, Aves Lab) and in the appropriate colloidal
gold-conjugated secondary antibody (1:50; UltraSmall; Aurion,
Wageningen, The Netherlands). The samples were post-fixed in 1%
osmium and 7% glucose for 30 min, rinsed, dehydrated, and
embedded in araldite (Durcupan; Fluka, Buchs, Switzerland). To
identify the YFP1 cells contacting the central canal lumen, semithin
sections (1.5 lm) were cut with a diamond knife and stained with
toluidine blue. For the ultrastructural characterization of YFP1 cells,
40–60 serial ultrathin sections (60–70 nm) of each YFP1 cell (n 5
6) were cut with a diamond knife, stained with lead citrate, and
examined under a transmission electron microscope (Tecnai Spirit
G2; FEI, Eindhoven, The Netherlands) by using a digital camera
(Morada, Soft Imaging System; Olympus, Tokyo, Japan). We photo-
graphed every section for cilia reconstructions. Adjustment of bright-
ness and contrast of the pictures, if needed, was performed with
Adobe Photoshop (Adobe Systems, San Jose, CA).
IMAGE ANALYSIS. For quantitative analysis of immunohisto-
chemistry, the forebrain was subdivided in the following subregions:
SVZ (from bregma 20.1 to 11.18), the rostral migratory stream
(RMS; from bregma 11.98 to 12.96), and the olfactory bulb (OB;
from bregma 13.08 to 14.28). Spinal cords were divided in the three
subregions (i.e., cervical, thoracic and lumbar enlargements). The SC
injured tissue was analyzed on 40 mm coronal sections spanning 62
mm from the lesion core. For the three regions studied (i.e., forebrain,
SC, and SCI), analysis was performed on series of 40 mm thick cross
sections spaced 200 mm from each other. Immunostainings were ana-
lyzed on confocal stacks (step size of 1 mm) acquired with laser scan-
ning microscopes (SPE II, Leica, DE www.leica-microsystems.com;
FV1000, Olympus, JP, www.olympusmicro.com). Presence of YFP1
spheres in culture was analyzed by a binocular microscope (Leica
MZFLIII) equipped with YFP-specific filter cube (k 527 nm). At least
50 neurospheres showing a diameter of 40 mm were counted in
each experiment. Neurospheres showing heterogeneous YFP expression
(as described in Coles-Takabe et al., 2008, see also spheres indicated
with a # in Supp. Info. Fig. 2D) were not included in the quantifica-
tions. Only YFP1 spheres showing full recombination (indicated with
an arrow in Supp. Info. Fig. 2D) were counted as positive. Recom-
bined and non-recombined spheres with a diameter <40 lm were
not included in our quantifications (Supp. Info. Fig. 2D, two YFP1
small neurospheres are indicated with an asterisk). Images were ana-
lyzed with the ImageJ, LASAF (Leica) and Imaris (Bitplane, www.bit-
plane.com) softwares; final figures were assembled with Adobe
Photoshop CS5 software. Statistical analysis was performed by
unpaired t-test or Two-ways ANOVA (Prism; GraphPad). All quantifi-
cations are presented as mean 6 SEM. N refers to the number of ani-
mals or independent in vitro experiments used for the quantifications.
Results
GFAPCreERT2 Mice Allow Successful Fate Mapping
of SVZ NSCs
NSCs of the adult SVZ express the glial intermediate fila-
ment protein GFAP (Doetsch et al., 1999; Ganat et al.,
2006; Garcia et al., 2004). We confirmed the reliability of
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the hGFAPCreRT2 mouse line with previously reported
observations by analyzing the forebrain of this mouse line at
different time points (i.e., 1, 10, and 30 days) following
tamoxifen administration. The transgenic line, time points
and labeling paradigms are depicted in Fig. 1. Successful
recombination was already evident 1 day following tamoxifen
treatment, in the parenchyma around the ventricles as well as
in the SVZ (Fig. 2A). Confocal analysis confirmed GFAP
expression by all recombined parenchymal YFP1 astrocytes as
well as by SVZ YFP1 cells exhibiting a radial morphology
(Fig. 2B). Importantly, at this early time point no YFP1
expression was detected in type-C (i.e., progenitors) and type-
A (i.e., committed neuroblasts) SVZ cells, labeled with
Mash1 and Dcx, respectively. We next assessed expression of
the helix-loop-helix transcription factor ID1, a previously
described marker of type-B1 SVZ (Azim et al., 2012; Nam
and Benezra, 2009). As many as 43.8% 6 2.3% (mean 6
SEM, N 5 3, cells: 120; Fig. 2C) SVZ YFP1 cells expressed
ID1, suggesting the presence of a large number of NSCs
among the population of recombined SVZ astrocytes. Con-
versely, 31.4% 6 11.8%, (N 5 3, cells: 40) of the ID11 cells
expressed YFP at this early time point, suggesting that about
one third of SVZ-NSCs had successfully recombined.
Fate mapping analysis of the recombined cells was per-
formed 10 and 30 days following recombination. At 10 days
post-tamoxifen treatment, the lateral and dorsal walls of the SVZ
(Fig. 2D), as well as the dorsolateral RMS and olfactory peduncle
(Fig. 2I), were densely populated by YFP1 cells, suggesting an
enlargement of the pool of the recombined cells by proliferation.
At this time point, the majority of recombined cells were positive
for GFAP (79.3 6 3.3%, N 5 3, cells: 453; Fig. 2B), Nestin
(71.7 6 8.9%, N 5 3, cells: 399; Fig. 2E), Vimentin (71.5 6
2.1%, N 5 3, cells: 404; Fig. 2F), and the radial glial marker
BLBP (Fig. 2G), supporting their Type-B cell (i.e., NSCs) iden-
tity. The remaining YFP1 cells comprised a mixed population of
Type-C (Mash11, Fig. 2H) and Type-A cells (DCX1, Fig. 2I).
The proportion of recombined type-C cells remained stable over
time, representing 37.6 6 5.3% (N 5 3, cells: 735) and 35.6 6
0.6% (N 5 3, cells: 342) of all Mash11 cells at 10- and 30-day
post-tamoxifen treatment. Recombined DCX1 neuroblasts
invading the olfactory bulb (OB) were observed at 10 days while
mature NeuN1 recombined neurons were only observed in the
OB granular layer 30 days post-tamoxifen treatment (Fig. 2L).
Altogether, these results indicate successful recombina-
tion in approximately one third of the neurogenic type B1
cells in the adult SVZ. These cells showed the hallmark char-
acteristics of aSVZ-NSCs, i.e., self-renewal as illustrated by
the stable number of type-C cells observed at 10 and 30
days, as well as neurogenic potential shown by the sequential
acquisition of the neuronal markers DCX and NeuN.
FIGURE 1: Schematic illustration of transgenic line and labeling paradigms. (A) Mice expressing a tamoxifen (Tam)-inducible Cre recombi-
nase (i.e., CreERT2) under the control of the human GFAP (hGFAP) promoter were crossed with the reporter line Rosa26-flox-stop-flox-
YFP. (B) Recombination was induced by a regime of 5 days of Tam injections. Animals were sacrificed at 1, 10, and 30 days after the
last Tam injection for histological analysis of the recombined cells in the forebrain. Neurospheres were derived from animals sacrificed 7
days “post-Tam treatment.” (C) For analysis of the recombined cells in the spinal cord, animals received a spinal cord injury (or a sham
operation) 7 days post-Tam treatment and were sacrificed 3 days later, for histology or preparation of neurospheres cultures. [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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FIGURE 2: Fate mapping of GFAP-expressing neural stem cells in the adult forebrain. (A–C) One day after the last Tamoxifen (Tam) injec-
tion, a population of cells surrounding the lateral ventricle showed successful recombination. All the recombined cells expressed GFAP,
confirming the reliability of the hGFAP-CreERT2 model (B). Based on the expression of the marker ID1 (C), we estimated that around
30% of recombined cells were NSCs (refer text for details). (D–G) Density of recombined cells greatly increased 10 days after recombi-
nation in the SVZ. Expression of the progenitor markers Nestin (E), Vimentin (F), and BLBP (G) was confirmed in a major population of
recombined cells. (H,I) At 10 days post-Tam treatment, clusters of Mash11 (i.e., type C) cells were observed in the SVZ (H), as well as
Dcx-expressing (i.e., type A) cells in the RMS and olfactory peduncle (I). (L) Neurons expressing the mature neuronal marker NeuN could
only be observed in the granular layer of the olfactory bulb, 30 days after the induction of recombination. Scale bars: 20 mm (A, D); 10
mm (B, C, E, G, I, L), and 5 mm (H, F). Abbreviations: LV, lateral ventricle; OP, olfactory peduncle; GCL, granule cell layer. [Color figure
can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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GFAPCreERT2 Mice Allow Successful Fate Mapping
of Spinal Cord Parenchymal and Central Canal-
Contacting Astrocytes
We next analyzed the pattern of recombination in the spinal
cord of the GFAPCreERT2 mice at 10 days post-tamoxifen
treatment. A large number of YFP1 cells were homogene-
ously distributed throughout the white (WM) and grey (GM)
matter, and were positive for GFAP (Supp. Info. Fig. 1A, B).
In agreement with a previous report (Hirrlinger et al., 2006),
recombination efficiency was higher in the SC compared with
the forebrain, with 77.5% 6 1.3% (N 5 3, cells: 173) of the
WM fibrous astrocytes, and 81.9% 6 2% (N 5 3, cells:
654) of the GM population of protoplasmic astrocytes
expressing YFP. Recombined cells were negative for the neu-
ronal marker NeuN and only rarely expressed the oligoden-
droglial marker APC (<0.5%; Supp. Info. Fig.1C,D). Thus,
recombination occurred in a majority of parenchymal GFAP1
astrocytes, a population of cells that lack neurospheres-
forming capacities (Barnabe-Heider et al., 2010).
Interestingly, recombined cells were also observed
around the central canal (CC; Fig. 3A), a region considered
to be a niche for quiescent NSCs (Barnabe-Heider et al.,
2010; Sabourin et al., 2009). In 40 mm thick SC coronal sec-
tions, between 1 and 4 recombined cells per section were
found in the ependymal layer (Fig. 3A). Sub-ependymal
astrocytes, located immediately below ependymal cells, were
also common (Fig. 3A, indicated with a star), but were not
included in our analysis. GFAP-expressing cells residing in
FIGURE 3: Fate mapping in the adult intact spinal cord reveal a population of periaqueductal GFAP expressing cells. (A) A population of
recombined cells was observed close to the spinal cord central canal 10 days after tamoxifen treatment. Based on their GFAP immunoreactiv-
ity and typical morphology YFP1 cells were identified as Acc (i.e., central canal-contacting astrocytes). Peri-ependymal astrocytes (indicated
with the asterisks), were often observed but were not included in the analysis. (B) Recombined Acc expressed the progenitor marker Nestin,
around the cell body and along the apical (arrow) and basal GFAP1 processes. (B0–B000) show a single plane image and 3D reconstruction of the
cell in B. GFAP immunodetection showed weak expression in the soma, but stronger expression in the basal (data not shown) and apical (B00)
processes. (C) Quantification of recombined Acc throughout the spinal cord revealed that an average of 2 6 0.8 cells were observed in 40 mm
thick coronal sections (N 5 3, 172 cells quantified in 85 sections) with no quantitative differences between the cervical, thoracic, and lumbar
subregions of the spinal cord. Analysis of their distribution revealed that the vast majority (i.e., 80.2 6 7.4%, N 5 3, cells: 172) of YFP1 Acc
resided in the dorsal pole of the CC. Scale bars: 10 mm. Abbreviations: GM, gray matter; WM, white matter; CC, central canal; D, dorsal; M,
medial; V, ventral. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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the SC ependymal cell layer have recently been defined as
CC-contacting astrocytes (Acc; Alfaro-Cervello et al., 2012), a
nomenclature that we used thereafter. Recombined Acc
indeed showed a radial bipolar morphology, with an apical
process contacting the lumen of the CC and a basal process
running medially along the SC groves. These YFP1 cells
strongly expressed GFAP along both their basal and more
weakly in their apical processes (Fig. 3B, arrowheads). In
FIGURE 4: Pre-embedding immunogold detection of YFP. (A) Flat Durcupan embedded section showing immunogold-labeled YFP1 cell
(arrows). (B) Toluidine blue-stained semithin section showing gray immunogold–silver labeling for YFP in one cell and its thin expansion
in contact with the central canal lumen. (C,D) TEM details of the immunogold-labeled cell thin expansion showing typical characteristics
of Acc: light cytoplasm and intermediate filaments (asterisk). (E) TEM serial sectioning of the labeled cell displaying a typical single cilium
basal body (arrow) with an orthogonally oriented centriole (arrowhead). (F) Schematic representation of a typical dorsal Acc cell with
detailed structural organization of the cilium. The core structure of Acc cilia is composed of nine outer microtubule doublets (9 1 0 con-
figuration) extending from the basal body. The basal body, which is a modified mother centriole, is associated with a perpendicular
daughter centriole. The ciliary membrane is continuous with the plasma membrane. Scale bar: 10 lm (B); 1 lm (C); 500 nm (D–E). [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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addition, they expressed the progenitor markers Nestin (Fig.
3B) and Vimentin (data not shown), as well as Sox2 and b-
catenin (Supp. Info. Fig. 1E, G) but not the SVZ-NSC
markers Id1 and BLBP (data not shown). Furthermore, Acc
were negative for the tight junction protein connexin-30
(Supp. Info. Fig. 1F) which was strongly expressed in peri-
ependymal (Supp. Info. Fig. 1 H) and parenchymal astrocytes
(data not shown). Thus, both morphological and marker
expression, distinguish Acc from parenchymal astrocytes and
suggest that Acc might retain NSC characteristics.
On average, we found 2 6 0.8 Acc/section (N 5 3,
172 cells quantified in 85 sections) throughout the rostro-
caudal SC extent (Fig. 3C). Quantification of Acc in three
arbitrarily defined CC subregions (dorsal, medial, and ventral;
Fig. 3C, inset) showed that the vast majority of YFP1 Acc
were found in the dorsal-most region of the CC (80.2 6
7.4%, N 5 3, cells: 172), with the remaining cells distributed
evenly between medial zone and ventral pole (respectively, 9.6
6 5.4% and 10 6 2.1%, N 5 3). This distribution of YFP1
Acc was conserved along the cervical, thoracic and lumbar
regions of the SC (Fig. 3C).
By using electron microscopy in combination with YFP
immunogold staining, we confirmed the astroglial identity of
YPF1 cells contacting the CC lumen (Acc; Fig. 4A,B). These
cells had light cytoplasm, nuclei with irregular borders and
thick bundles of intermediate filaments homogeneously dis-
tributed within the cytoplasm, in contrast to the clumped
organization of ependymal cells intermediate filaments (Fig.
4C,D). In addition, labelled cells contacted the central canal
through a thin process and had a single cilium and associated
daughter centriole (Fig. 4E). Interestingly, one of the 5 three-
dimensional reconstructed cells showed a single cilium with a
large and electron dense basal body, resembling the biciliated
Ecc basal bodies.
SVZ and Spinal Cord Neurospheres Derived from
GFAP1 Progenitors Differ in their Frequency and
Self-Renewing Capabilities
NSCs identity is classically assessed in vitro, by performing
neurosphere assays (Brewer and Torricelli, 2007). In order to
assess the contribution of SVZ and spinal cord GFAP-
expressing cells to neurosphere formation, we derived neuro-
spheres cultures from these two regions, 10 days post-
tamoxifen treatment. Primary neurospheres (P0; Fig. 5A)
appeared between 7–14 d.i.v. in the two samples. When the
SVZ-derived cultures were examined under an epifluorescent
binocular microscope, 35.8 6 2.4% (N 5 4, spheres: 192) of
the neurospheres showed full recombination indicating their
clonal origin from GFAP-expressing cells. In contrast, only
16.8 6 0.5% (N 5 3, spheres 5 124; P 5 0.0025, t-test;
Fig. 5B) of the spinal cord primary neurospheres showed YFP
expression. Notably, while the proportion of recombined neu-
rospheres remained stable over several passages in the SVZ-
derived cultures (t-test, P > 0.5), it rapidly decreased in SC-
derived cultures (P0 to P1, t-test: P < 0.001; P1 to P2,
t-test: P < 0.05) to fully disappear at passage 4 (Fig. 5B,C).
Recombined spinal cord and SVZ-derived P1 neurospheres
showed comparable multipotency (Fig. 5D,E). Upon differen-
tiation, recombined SC-neurospheres gave rise to 47.5 6
7.2% Map21 neurons and 38 6 8.4% GFAP1 astrocytes (N
5 3, cells 5 728; Fig. 5E). Similarly, recombined SVZ-
neurospheres gave rise to 57.9 6 0.5% neurons and 32.8 6
0.9% astrocytes (N 5 3, cells: 1100; Fig. 5E). In all cultures,
rare RIP1 oligodendrocytes were obtained from YFP1 cells
following 2 weeks of differentiation (data not shown). Thus,
GFAP1 cells of the adult spinal cord retain multipotentiality
but have a limited capacity for self-renewal when compared
with SVZ-GFAP1 cells.
Spinal Cord Injury Increases GFAP1 Cells
Proliferation Near the Central Canal
To characterize the response of recombined GFAP1 cells to
spinal cord injury (SCI), we performed a thoracic (Th8) com-
pression injury. In order to prevent recombination in cells
that would up-regulate GFAP following injury, GFAPCreRT2
mice were injured 7 days following the last tamoxifen injec-
tion, a delay sufficient for full clearance of the drug. Adminis-
tration of EdU over a 3-day period (starting at 1 d.p.i.)
revealed a dramatic increase in the number of proliferating
cells following injury (compare Fig. 6A,B), in agreement with
previous studies (Zai and Wrathall, 2005). In the parenchyma
surrounding the CC, the density of EdU-incorporating cells
increased from 1.4 3 103 6 0.1 3 103 cells/mm3 (in intact
conditions; N 5 3, cells: 133) to 69.7 3 103 6 2.2 3 103
cells/mm3 (i.e., 50-fold increase, t-test: P < 0.005, N 5 3;
cells: 3906; Fig. 6C). As previously described, parenchymal
astrocytes represented a significant proportion of these prolif-
erating cells (i.e., 14 6 4%, N 5 3; cells: 898; P < 0.05
compared with intact tissue, t-test; Fig. 6D).
Analysis of the ependymal cell layer in proximity to the
site of injury revealed a similar marked increase in the EdU-
labeled cells when compared with the intact SC (45 6 2.1
cells/section vs. 1.8 6 0.5 cells/section, respectively; i.e., a
25-fold increase, t-test: P < 0.005, N 5 3 per group, cells:
intact 59, injury 897, Fig. 6E). In agreement with their low
density, recombined Acc represented only 2.5 6 1.2% of all
the EdU labeled cells in the CC ependymal cell layer in the
intact spinal cord (N 5 3, sections: 85, cells: 179). Following
injury, they however profoundly enhanced their proliferation
(10.3 6 3.7 YFP1/EdU1 cells/section, N 5 3, cells: 209),
representing 23.8 6 9.7% of the EdU1 CC cells (N 5 3, t-
test: P < 0.05; Fig. 6F). In agreement with results obtained
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from the intact spinal cord (see above) only rare EdU1
recombined Acc were observed in SC regions distant from
the injury site (i.e., the spared cervical and lumbar enlarge-
ments). These results confirm that the proliferation of CC
cells is locally increased by the spinal cord injury (Meletis
et al., 2008). Furthermore, they show that Acc represent a
non-negligible proportion (i.e., 1/5th) of the total CC cells
undergoing mitosis in response to SCI.
SCI Promote the Self-Renewal Properties of GFAP-
Derived Spheres
In order to investigate the effect of SCI on the multipotency
and self-renewal properties of GFAP1 cells, neurosphere cul-
tures were derived from intact and injured SC (Fig. 7A). The
proportion of primary YFP1 neurospheres was comparable
between the two cultures (Fig. 7B, t-test: P > 0.5), indicating
no recruitment of additional populations of GFAP1 progeni-
tors after SCI. In clear contrast, the self-renewal of the recom-
bined spheres was greatly enhanced after injury (Fig. 7B;
Two-ways ANOVA: P < 0.0001, F 5 3.98; intact N 5 4,
injury N 5 5). The diameter of the spheres at P0 and P1
was not significantly different between experimental condi-
tions (Fig. 7C). Multipotentiality was compared by plating
secondary (P1) neurospheres and exposing them to differenti-
ating conditions (Fig. 7D–F). Spheres from intact or injured
spinal cord showed similar neuronal (i.e., 47.5 6 7.2% for
intact and 48.5 6 6.6% for injured SC, N 5 3, 701 cells
analyzed), and astroglial differentiation (i.e., 38 6 8.4% and
33.4 6 4.1%), with rare oligodendrocytes being observed
(<0.2% of the cells; Fig. 7F). Non-recombined neurospheres
produced a similar proportion of Map21 neurons and
GFAP1 astrocytes in both conditions (intact-derived: 50.0 6
4.4% neurons and 36.4 6 1.2% astrocytes, N 5 3, cells 5
853; injured-derived: 46 6 2.4% neurons and 32.6 6 2.4%
astrocytes, N 5 3, cells 5 1139). Altogether, these results
indicate that SCI prolongs the proliferative capacities of
GFAP-expressing multipotent progenitors in the adult spinal
cord.
FIGURE 5: Neurospheres-forming potential of SVZ and spinal cord-derived recombined cells. (A) Numerous clonal YFP1 spheres were
observed in cultures prepared from the adult SVZ (data not shown) or spinal cord (A). (B,C) Quantification of the number of YFP1 neuro-
spheres revealed that 35.8 6 2.2% (N 5 4, spheres 5 192) of the primary SVZ spheres were recombined, demonstrating that they
derived from GFAP-expressing cells. The % of recombined spheres in these cultures did not show major changes over several passages
(B, black line). In contrast, 16.8 6 0.5% (N 5 3, spheres 5 124) of spinal cord-derived primary neurospheres showed recombination. SC-
derived YFP1 neurospheres dramatically decreased over three passages (C), and were absent from passage 4 on (B, red line). The first
three passages are analyzed in C where data are normalized for the % of YFP1 spheres in the primary (i.e., P0) cultures. While the pro-
portion of recombined neurospheres remained stable over several passages in the SVZ-derived cultures (t-test, P > 0.5), it rapidly
decreased in SC-derived cultures (P0 to P1, t-test: P < 0.001; P1 to P2, t-test: P < 0.05; >100 spheres counted for each passage in each
condition) to fully disappear at passage 4. *P < 0.05; ***P < 0.0001. (C–E) Despite marked differences in their self-renewal properties
(C); both SVZ and SC-derived neurospheres were shown to be multipotent (D, E). Three days after mitotic factor removal, many YFP1
cells had differentiated into GFAP1 astrocytes (red, asterisks) and Map21 neurons (blue, arrows), as quantified in D. Scale bars: 50 mm
(A); and 20 mm (C). Abbreviations: BF, bright field. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
2108 Volume 61, No. 12
Discussion
Here, we used inducible transgenic mice to label and fate map
populations of GFAP-expressing cells in the adult SC. We con-
firm the existence of a population of rarely dividing, CC-
contacting astrocytes (Acc; Alfaro-Cervello et al., 2012), residing
within the ependymal cell layer, i.e., the stem cell niche of the
adult SC (Hugnot and Franzen, 2011). By systematically assess-
ing their multipotent and self-renewal properties in vitro, we
show that GFAP-expressing Acc are progenitors capable to gen-
erate clonal multipotent neurospheres. These cells however
show limited self-renewal properties when compared with
GFAP-expressing SVZ-NSCs. Spinal cord injury enhanced Acc
proliferation in vivo, and prolonged the self-renewal properties
of GFAP-derived neurospheres in vitro. Our findings reconcile
FIGURE 6: Spinal cord injury induces proliferation of GFAP1 cells: (A) After a 3-days treatment with the mitotic marker EdU only rare
EdU-labeled cells were seen in the ependymal layer as well as in the parenchyma. (B) After injury, the number of EdU-positive cells
greatly increased close to the injury site, both in the parenchyma and CC, where many proliferating cells were recombined. (C,D) Quanti-
fication of EdU1 cells numbers in the parenchyma. Whereas proliferation was minimal in the intact parenchyma (white bars; 1.4 3 103 6
0.1 3 103 cells/mm3; N 5 3, cells: 133), injury resulted in a 50-fold increase in the number of EdU1 cells (gray bars; 69.7 3 103 6 2.2 3
103 cells/mm3; t-test: P < 0.005, N 5 3; cells: 3906). Only 2% of recombined astrocytes in the intact spinal cord incorporated EdU, while
following injury the proportion of recombined EdU1 cells increased to 14 6 4% (N 5 3; cells: 898; P < 0.05 compared with intact tissue,
t-test). (E) Following injury, a similar increase in proliferation could be observed in the spared CC 62 mm from the injury core Here,
EdU-labeled cells increased 25 fold compared with the intact situation (45 6 2.1 cells/section vs. 1.8 6 0.5 cells/section, respectively;
i.e., a 25-fold increase, t-test: P < 0.005, N 5 3, cells: 897). (F) Acc represented a minor population of CC EdU-incorporating cells in
intact situation (2.5% 6 1.2% YFP1EdU1/EdU1, N 5 3, sections: 85, cells: 179). After injury, the proportion of recombined proliferating
cells in the CC significantly increased to 23.8 6 9.7% YFP1EdU1/EdU1 (N 5 3, cells 5 209; t-test: P < 0.05), suggesting that Acc locally
enlarge their numbers after spinal cord injury. *P < 0.05; *P < 0.005; Scale bars: 30 mm (A, B). [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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divergent views on the identity of SC-NSCs (Hugnot and Fran-
zen, 2011; Sabelstrom et al., 2013) by showing that cells from
both GFAP-positive and -negative lineages are multipotent in
the adult spinal cord. Our long-term fate mapping experiments
however reveal that, in striking contrast to the aSVZ, GFAP-
positive cells of the adult spinal cord show only limited self-
renewal even after injury. These observations identify them as
multipotent progenitor cells.
FIGURE 7: Spinal cord GFAP1 progenitors increased self-renewal after injury. (A,B) Comparison of the number and self-renewal properties
of recombined neurospheres isolated from the intact (black line) and injured (red line) spinal cord. Data represent repeated independent
experiments (Intact: N 5 4; Injury: N 5 5; 2 mice used in each experiment). Whereas the proportions of primary recombined neurospheres
were similar (Intact: 15.9 6 4.5%, N 5 4, 152 spheres counted; Injury: 21.1 6 4.5%, N 5 5, 246 spheres; t-test: P > 0.5), injury greatly
increased their self-renewal capacity (Two-ways ANOVA: significant culture 3 passage interaction, P < 0.0001, F 5 3.98; asterisks in B mark
the passages with significant difference between intact- and injury-derived cultures based on post-hoc comparison using the error variance
associated with the significant culture 3 passage interaction. *P < 0.05; ***P < 0.0001). Despite a clear decrease in the number of recom-
bined neurospheres over passages, YFP1 neurospheres prepared form injury animals could still be observed after eight passages. (C) Diame-
ters of the neurospheres were compared at P0 and P1. No significant differences were found between YFP1 (i.e., Acc-derived) and negative
(i.e., ependyma-derived) neurospheres. (D–F) Similarly, multipotency in a differentiation assay did not show significant differences between
the two experimental conditions. The vast majority of cells differentiated in Map21 neurons (E, arrows) and GFAP1 astrocytes (E, asterisks)
while rare RIP1 oligodendrocytes were observed after 2 weeks in culture (F). Scale bars: 50 mm (A); and 20 mm (E). Abbreviations: BF, bright
field. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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The transgenic model used here is based on the human
GFAP promoter (hGFAP, Hirrlinger et al., 2006) controlling
expression of an inducible Cre recombinase. This approach
has been used in several studies to drive recombination in
GFAP-expressing cells of the forebrain or spinal cord, either
directly (hGFAP-GFP, Beckervordersandforth et al., 2010; Platel
et al., 2009; Sabourin et al., 2009), or via Cre/Lox methods
(hGFAP-Cre; Ganat et al., 2006; Malatesta et al., 2003). Our
immunostainings using either polyclonal or monoclonal GFAP
antibodies confirmed reliable hGFAP-driven transgene expression
in a population of GFAP-expressing cells that is in close contact
to the ventricular system in both the SVZ and SC. Based on the
use of stem and progenitor cells markers (ID1 and Mash1,
respectively; Nam and Benezra, 2009; Parras et al., 2004), we
estimated that around 30% of the NSCs population recombined
in the adult SVZ. In contrast to the SVZ, the recombination
efficiency was superior to 80% in parenchymal GFAP1 cells of
the spinal cord, while accurate quantification in the CC region
was rendered difficult due to the cytoplasmic expression of
GFAP and the clustering of the positive cells. Whereas this
region-dependent variability of the recombination efficiency
(Hirrlinger et al., 2006; Malatesta et al., 2003) prevented a direct
comparison of the frequency at which recombined cells contrib-
ute to neurosphere formation, it did not preclude comparison of
the multipotential and long term self-renewal properties of
GFAP-expressing cells derived from the SVZ and SC.
A neurosphere assay (Reynolds and Weiss, 1996) was
used in combination with hGFAP-fate mapping to assess and
compare the identity of cells with NSCs properties in the
SVZ and in the SC. Previous studies showed that GFAP-
expressing cells of the postnatal SVZ generate neurospheres
when exposed to mitotic factors FGF2 and/or EGF in vitro,
while juxtaposed ependymal cells fail to do so (Beckervorder-
sandforth et al., 2010; Chiasson et al., 1999). Our results
indeed showed that 30% of the multipotent SVZ neuro-
spheres showed persistent YFP-expression when serially pas-
saged, in agreement with our in vivo estimation of the rate of
recombination occurring in this region (see above). Recent
evidence suggests that this glial lineage of NSCs might not be
preserved in the spinal cord (Barnabe-Heider et al., 2010;
Obermair et al., 2010). In this region, neurospheres are
known to derive from cells residing near the central canal and
expressing the ubiquitous stem/progenitor marker Nestin, as
well as FoxJ1, a transcription factor involved in cilia forma-
tion (Meletis et al., 2008; Ostrowski et al., 2003). Hence,
ciliated ependymal cells would represent the main stem cell
population of the SC, in contrast with the SVZ situation.
Our results confirm that neurospheres only form in SC-
derived cultures when the central canal is included. The pres-
ence of a small but non-negligible population of recombined
neurospheres (20%) in our SC-derived cultures however
demonstrates the existence of a foreseen population of GFAP-
expressing cells, with multipotent properties, in the adult SC.
Thus, our results suggest that the CC ependymal cell layer is
composed of at least two sub-populations of cells that can
generate multipotent neurospheres. These two CC-contacting
cell populations can be distinguished by their expression of
GFAP (Alfaro-Cervello et al., 2012; Hamilton et al., 2009;
Sabourin et al., 2009), with ependymal cells (Ecc) being
GFAP-, while central canal-contacting astrocytes express this
marker (Acc; Alfaro-Cervello et al., 2012). Visualization of
these Acc by GFAP-driven transgenesis revealed that they are
enriched in the dorsal aspect of the CC throughout the spinal
cord. Our results show that they do not express connexin-30,
a marker of parenchymal astrocytes that lack the capacity to
produce neurospheres (Barnabe-Heider et al., 2010). In con-
trast, they show a high degree of phenotypic similarities to
the Type B1 cells of the SVZ (Supp. Info. Table 1), most
importantly expression of GFAP (Alfaro-Cervello et al., 2012;
Mirzadeh et al., 2008) and Hes1 (Ohtsuka et al., 2006; Sabo-
urin et al., 2009), the presence of one single apical cilium
and the daughter centriole (Alfaro-Cervello et al., 2012; Mir-
zadeh et al., 2008; Wyszynski et al., 1997), and a long basal
GFAP1 process (Hamilton et al., 2009; Mirzadeh et al.,
2008). Those features are also common to tanycytes (Hamil-
ton et al., 2009; Mothe and Tator, 2005), a subpopulation of
which (i.e., the a2-tanycytes) present neural progenitor prop-
erties in the dorsal regions of the third ventricle (Robins
et al., 2013). Further studies are necessary to fully clarify sim-
ilarities in between these three cell types.
A previous short-term fate mapping study using the
hGFAP-GFP mouse line suggested that Acc may participate
to neurosphere formation, although clonal analysis and long-
term fate mapping were not performed (Sabourin et al.,
2009). Our results confirm the capacity of those cells to form
clonal multipotent primary spheres. However, the persistent
expression of the reporter gene together with serial passaging
demonstrates a rapid disappearance of the recombined neuro-
spheres. Thus, unlike SVZ-NSCs, GFAP-expressing cells of
the adult SC are multipotent progenitors that lack the long-
term self-renewal potential of neural stem cells. These results
highlight the heterogeneity of cell lineages showing NSCs
properties in neurogenic and non-neurogenic regions of the
adult CNS. Interestingly, the in vitro self-renewal properties
appeared to be directly correlative with the in vivo prolifera-
tive behavior of the recombined cells. Our analysis indicates
that proliferation is indeed very limited in the intact spinal
cord CC. After spinal cord injury, a dramatic increase of Acc
proliferation was paralleled by an increase in the self-renewal
properties of recombined neurospheres in our in vitro assay.
However, it should be noted that even after injury, the self-
renewal properties of GFAP-derived neurospheres isolated
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from the SC failed to match those of the SVZ, therefore con-
firming their progenitor identity.
It is unclear whether cells surrounding the spinal
cord CC are homogeneous in showing progenitor proper-
ties in vitro, or if these properties are only shared by a
subset of spatially restricted cells. Microdissection experi-
ments have suggested that neurosphere forming capabil-
ities are mostly restricted to the dorsal portion of the
spinal cord CC (Sabourin et al., 2009), a region where we
observed the highest density of recombined Acc. Interest-
ingly, although these cells represent a small populations of
ependymal cells (that we estimated to be <0.5% of all CC
nuclei), they contributed to the formation of as many as
15% of all primary neurospheres. This suggest that only a
subpopulation of CC, most likely residing in its dorsal
most region, show neurosphere forming capacities (Mart-
ens et al., 2002; Sabourin et al., 2009). This dorsal region
indeed contains most of the actively proliferating cells
(80% of the EdU1 cells, data not shown), further sup-
porting heterogeneity of the CC.
We propose that the GFAP-expressing Acc described in
this article represent a subpopulation of the previously
described neurosphere-forming ependymal cells (Barnabe-
Heider et al., 2010; Meletis et al., 2008). Indeed, rare epen-
dymal cells with clear radial morphology were observed to
recombine in both the Foxj1-CreERT2 and Nestin-
CreERT2 mice lines (Meletis et al., 2008). Our immuno-
staining results indeed confirmed Nestin expression in Acc
recombined cells. Although we could not performed immu-
nostaining for FoxJ1 due to a lack of a specific antibody, it
should be noted that this marker is expressed in a subset of
SVZ GFAP1 astrocytes of the adult SVZ (Jacquet et al.,
2009). Following injury, SVZ FoxJ1-expressing astrocytes
are activated and replenish the population of ependymal
cells (Carlen et al., 2009; Jacquet et al., 2009). Our observa-
tion of a loss of polarity and increased densities of YFP-
expressing cells in the regions of the CC close to the injury
site (Fig. 6), suggests that a comparable regenerative process
may occur in the SC. Future experiments based on split-Cre
technology may allow addressing more in details the diver-
sity and lineage relationship of cells types that populate the
spinal cord CC.
Altogether, our work supports heterogeneity and
regional distribution of stem/progenitor populations in the
spinal cord CC. Rather than being a feature of a unique cell
type, multipotent neurospheres formation is a property of
two periaqueductal cell populations that differ according to
GFAP expression and their in vivo/in vitro proliferation
potential. Our study identifies GFAP-expressing cells of the
spinal cord as multipotent progenitors, by showing that only
SVZ-recombined cells show the long-term self-renewal prop-
erties of NSCs. These observations highlight major differences
in the lineage of NSCs cells across the CNS neuraxis.
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